drugset / Trial / NCT07218445

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

NCT07218445

Phase 4 Recruiting 40 enrolled Mayo Clinic
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the effect of tirzepatide on vasomotor symptoms and on measures of biological aging.

Timeline

Start
2026-04-08
Primary completion
2027-09-18
Completion
2027-09-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Tirzepatide Peptide 15 mg Subcutaneous